This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 19, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 19, 2024

Scientific Program Partner

Meeting agenda created in conjunction with The Antibody Society.

December 15 - 19, 2024
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 19, 2024

Thank you for joining us in 2023! More information on 2024 coming soon...


The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more...

Register your interest for the 2024 event to get first access to the agenda!

Celebrating 34 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices

Brand New Session Themes for 2023:

  • Preclinical Development of Antibody Drugs: From Discovery to IND
  • The Promise and the Challenges of Machine Learning and AI In Antibody Discovery
  • Antibody Discovery, Selection and Engineering
  • Novel Bispecifics, Multi-specifics and Therapeutic Combinations
  • Antibody Therapies in Tumor Microenvironment
  • Protein-Based Degraders for Therapeutic Development

Brand New Session Themes for 2023:

  • Harnessing Antibodies for Autoimmunity and Inflammation
  • Immune Cell Engager Antibody Technologies
  • Engineering Antibody Immune Agonists
  • Antibody Therapy for Neurodegenerative Diseases
  • Antibody-Based Cell Therapies
  • Antibody-based Drugs: Clinical Translation and Lessons Learned

3 Unmissable Add-On Options for 2023:

Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference. 

Options include:

  • Pre-Conference Half-Day Workshop A (PM): Pre-clinical Development of Antibody Drugs: From Discovery to IND
  • Pre-Conference Half-Day Workshop B (PM): Artificial Intelligence and Machine Learning in Antibody Discovery
  • Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering

Michael Kierny, PhD

Scientist I


With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

About the Antibody Society

The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community.

Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee. 

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Contact Blake Shuka:

Vaishali Kapoor


Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.